Turn this role into an interview — a resume and cover letter built around what this employer wants.
Initial Therapeutics, Inc. is seeking a Post Doctoral Fellow to conduct research on E3 ligase recruitment and molecular glue discovery. Candidates should have a PhD in a relevant field and a strong background in cell biology or biochemistry.
This role involves designing experiments, collaborating on proteomics studies, and contributing to scientific publications. The position promises excellent opportunities for scientific growth and high-impact publication authorship.
The Post Doctoral Fellow at Amgen conducts research under the supervision of a mentor. They contribute to the design and execution of research projects, the analysis of data, and the preparation of scientific manuscripts.
This postdoctoral project focuses on understanding how biochemical state, cellular context, and subcellular localization influence substrate recruitment to E3 ligases such as Cereblon (CRBN). The fellow will leverage cutting‑edge in‑cell proximity labeling technologies (TurboID), quantitative proteomics, and cellular perturbation approaches to define mechanistically meaningful recruitment events relevant to molecular glue discovery.
The position is ideal for candidates with strong training in cell biology, molecular biology, or biochemistry, particularly in ubiquitin biology, targeted protein degradation, or E3 ligase biology, who are interested in applying proteomics approaches to mechanistic questions in targeted protein degradation.
Prior hands‑on proteomics expertise is not required; however, familiarity with proteomics approaches and enthusiasm for learning advanced quantitative proteomics methodologies are highly desirable.
The fellow will join a highly collaborative environment at the intersection of proteomics, TPD biology, and translational drug discovery. The project leverages established high‑throughput TurboID proximity labeling workflows, advanced quantitative proteomics platforms, and close collaborations across discovery biology and proteomics teams.
This position offers outstanding opportunities for scientific growth in induced proximity biology, quantitative proteomics, and translational therapeutic discovery, with expected authorship on high‑impact publications.
Amgen is an Equal Opportunity employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability status, or any other basis protected by applicable law. We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.